Damora Therapeutics, Inc 10-K for FY2022
Damora Therapeutics, Inc. (DMRA)
10-K
2023-03-09
For: 2022-12-31
View Original
Added on
April 07, 2026
About this 10-K
Damora Therapeutics, Inc filed this 10-K on March 9, 2023, covering the fiscal year ended December 31, 2022 (FY2022).
Headline figures
Fiscal year ended December 31, 2022, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Net loss
- $61.62M
- compared with a net loss of $51.75M a year earlier
- Diluted EPS
- -$2.43
- compared with -$2.05 a year earlier